References
Krieg T, Meurer M (1988) Systemic scleroderma. Clinical and pathophysiological aspects. J Am Acad Dermatol 18:457–481
Fleishmajer R, Perlish JS, Reeves JRT (1977) Cellular infiltrates in scleroderma skin. Arthritis Rheum 20:975–984
Roumm AD, Whiteside TL, Medsger TA Jr, Rodnan GP (1984) Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations. Arthritis Rheum 27:645–650
Adamson IVR, Bowden DH (1974) The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 77:185–198
Aso Y, Yoneda K, Kikkawa Y (1976) Morphological and biological study of pulmonary changes induced by bleomycin in mice. Lab Invest 35:558–568
Chandler DB (1990) Possible mechanisms of bleomycin-induced pulmonary fibrosis in mice. Clin Chest Med 11:21–30
Thrall RS, Lovett EJ, Barton RW, McCormick JR, Phan SH, Ward PA (1980) The effect of T cell depletion on the development of bleomycin induced pulmonary fibrosis in the rat. Am Rev Respir Dis 121:A99
Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P (1989) Tumor necrosis factor/cachectin plays a key role in bleomycin induced pneumopathy and fibrosis. J Exp Med 170:655–663
Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG (1979) Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis 120:893–899
Schrier DJ, Phan SH, McGarry BM (1983) The effects of nude (nu/nu) mutation on bleomycin induced pulmonary fibrosis. A biochemical evaluation. Am Rev Respir Dis 127:614–617
Yamamoto T, Takagawa S, Katayama I, Yamazaki K, Hamazaki Y, Shinkai H, Nishioka K (1999) Animal model of sclerotic skin. I: Repeated injections of bleomycin induce dermal sclerosis mimicking scleroderma. J Invest Dermatol 112:456–462
Yamamoto T, Takahashi Y, Takagawa S, Katayama I, Nishioka K (1999) Animal model of sclerotic skin. II: Bleomycin-induced scleroderma in genetically mast cell deficient WBB6F1-W/Wv mice. J Rheumatol 26:2628–2634
Yamamoto T, Kuroda M, Nishioka K (2000) Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Arch Dermatol Res 292:535–541
White B (1994) Immune abnormalities in systemic sclerosis. Clin Dermatol 12:349–359
Gruschwitz MS, Moormann S, Kromer G, Sgonc R, Dietrich H, Boeck G, Gershwin ME, Boyd R, Wick G (1991) Phenotypic analysis of skin infiltrates in comparison with peripheral blood lymphocytes, spleen cells and thymocytes in early avian scleroderma. J Autoimmun 4:577–593
Walker MA, Harley RA, DeLustro FA, LeRoy EC (1989) Adoptive transfer to Tsk skin fibrosis to +/+ recipients by Tsk bone marrow and spleen cells. Proc Soc Exp Biol Med 192:196–200
Phelps RG, Daian C, Shibata S, Fleischmajer R, Bona CA (1993) Induction of skin fibrosis and autoantibodies by infusion of immunocompetent cells from tight skin mice into C57BL/6 Pa/Pa mice. J Autoimmun 6:701–718
Wallace VA, Kondo S, Kono T, Xing Z, Timms E, Furlonger C, Keystone E, Gauldie J, Sauder DN, Mak TW, Paige CJ (1994) A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice. Eur J Immunol 24:1463–1466
Lake-Bullock MHV, Zhu J, Hao H, Cohen DA, Kaplan AM (1999) T cell independence of bleomycin-induced pulmonary fibrosis. J Leukoc Biol 65:187–195
Yamamoto T, Nishioka K (2001) Animal model of sclerotic skin. IV: Induction of dermal sclerosis by bleomycin is T cell independent. J Invest Dermatol 117:999–1001
Yamamoto T, Eckes B, Krieg T (2000) Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Arch Dermatol Res 292:556–561
Breen E, Shull S, Burne S, Absher M, Kelley J, Phan S, Cutroneo KR (1992) Bleomycin regulation of transforming growth factor-β mRNA in rat lung fibroblasts. Am J Respir Cell Moll Biol 6:146–152
King SL, Lichtler AC, Rowe DW, Xie R, Long GL, Absher MP, Cutroneo KR (1994) Bleomycin stimulates proα1(I) collagen promoter through transforming growth factor-β response element by intracellular and extracellular signaling. J Biol Chem 269:13156–13161
Sfikakis PP, McCune BK, Tsokos M, Aroni K, Vayiopoulos G, Tsokos GC (1993) Immunohistological demonstration of transforming growth factor-β in the skin of patients with systemic sclerosis. Clin Immunol Immunopathol 69:199–204
Gay S, Jones RE Jr, Huang G, Gay RE (1989) Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 92:301–303
Sato M, Ishikawa O, Miyachi Y (1996) An immunohistochemical study on transforming growth factor-β in the skin of systemic sclerosis patients with reference to the histopathologic stage. Eur J Dermatol 6:482–485
Myers SL, Cohnen JS, Sheets PW, Bies JR (1986) B-mode ultrasound evaluation of skin thickness in progressive systemic sclerosis. J Rheumatol 13:577–580
Ballou SP, Mackiewicz A, Lysikiewcz A, Neuman MR (1990) Direct quantitation of skin elasticity in systemic sclerosis. J Rheumatol 17:790–794
Richard S, Querleux B, Bittoun J, Idy-Peretti I, Jolivet O, Cermakova E, Leveque J-L (1991) In vivo proton relaxation times analysis of the skin layers by magnetic response imaging. J Invest Dermatol 97:120–125
Falanga V, Bucalo B (1993) Use of a durometer to assess skin hardness. J Am Acad Dermatol 29:47–51
Bjerring P (1985) Skin elasticity measured by dynamic admittance: a new technique for mechanical measurements in patients with scleroderma. Acta Derm Venereol (Stockh) 120:83–87
Ishikawa T, Ishikawa O, Miyachi Y (1995) Measurement of the skin elastic properties with a new suction device (I); Its relationship to age, sex and the degree of obesity in normal individuals. J Dermatol 22:713–717
Cua AB, Wilhelm KP, Maibach HI (1990) Elastic properties of human skin: relationship to age, sex and anatomical region. Arch Dermatol 282:283–288
Hermanns-Le T, Jonlet F, Scheen A, Pierard GE (2001) Age- and body mass index-related changes in cutaneous shear wave velocity. Exp Gerontol 36:363–372
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamamoto, T., Nishioka, K. Animal model of sclerotic skin. VI: Evaluation of bleomycin-induced skin sclerosis in nude mice. Arch Dermatol Res 295, 453–456 (2004). https://doi.org/10.1007/s00403-003-0439-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-003-0439-y